#invest-al92

#invest-al92

Monthly payouts in 2026 have run $0.102, $0.105, and $0.108, tracking close to the $0.1055 average seen across 2025. That is a meaningful step up from the $0.0865 average in 2024.

Chinese stocks have spent the last five years really testing the patience of even the most hardcore contrarians. Between the property sector struggles, the crackdown on tech platforms, and the constant friction over chip exports and tariffs, valuations have been pushed down across the board.

The iShares Biotechnology ETF is the default large-cap vehicle for the sector. It is market-cap weighted, which concentrates the fund in cash-generative incumbents rather than spreading capital across clinical-stage names.

The GCC has made itself structurally indispensable to the global economy. This did not happen by accident. It is the result of decades of deliberate sovereign intent.

EMLC holds a broad mix of about 507 bonds issued by emerging market governments, all denominated in local currencies such as the Brazilian real, South African rand, Turkish lira, and Mexican peso. Almost the entire portfolio is sovereign debt at roughly 99 percent, so the fund is essentially a pure government credit exposure.

Some financial experts recommend enjoying a portion of the windfall while allocating the rest towards savings or investments to ensure long-term benefits.

In 2022, the classic 60/40 balanced portfolio of stocks and bonds didn't provide much protection. In fact, it lost nearly as much as a 100% equity portfolio.

The iShares U.S. Treasury Bond ETF holds only U.S. Treasury notes and bonds across the maturity curve, providing the cleanest expression of flight-to-quality stability in a single ticker. Credit risk is effectively zero because every holding carries the full faith and credit of the U.S. government.